Key Takeaway: The article discusses trends in clinical trials as part of a broader analysis of the biopharma landscape in 2025. It highlights the role of data science in transforming data gathering processes. The insights are part of a series by Scrip that aims to forecast future developments in the industry.
Price reaction · baseline $4.58 (2025-02-11 close) · hit pre-market · clean, no other FDMT news in the window
day 0 close · peak
-0.7%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+128%
120-day peak, hindsight
Typical move
11.2%
average across 9 past catalysts
Cash runway
~18 mo
Low dilution risk
Lead asset
4D-150 IVT
Phase 3 · Macular Neovascularization Secondary to Age-Related Macular Degeneration
Full Press Release Details
Scrip Asks... What Does 2025 Hold For Biopharma? Part 5: Clinical Trials Trends
Data Science Transforms Data Gathering
Feb 06 2025
By
Eleanor Malone
(Shutterstock)
Keep up with the top pharma business news of the week. On the go.